Montalto, Giuseppe
Montalto, Giuseppe
The potential of the nutraceutical berberine in the treatment of hepatocellular carcinoma and other liver diseases such as NAFLD and NASH
2024 Cervello, Melchiorre; Augello, Giuseppa; Cocco, Lucio; Ratti, Stefano; Follo, Matilde Y.; Martelli, Alberto M.; Cusimano, Antonella; Montalto, Giuseppe; Mccubrey, James A.
GSK-3? Can Regulate the Sensitivity of MIA-PaCa-2 Pancreatic and MCF-7 Breast Cancer Cells to Chemotherapeutic Drugs, Targeted Therapeutics and Nutraceuticals
2021 L Abrams, Stephen; M Akula, Shaw; K Meher, Akshaya; S Steelman, Linda; Gizak, Agnieszka; Duda, Przemysaw; Rakus, Dariusz; M Martelli, Alberto; Ratti, Stefano; Cocco, Lucio; Montalto, Giuseppe; Cervello, Melchiorre; Ruvolo, Peter; Libra, Massimo; Falzone, Luca; Candido, Saverio; A McCubrey, James
Hepatocellular Carcinoma: A Difficult Cancer to Treat
2021 Cusimano, Antonella; Soresi, Maurizio; Montalto, Giuseppe; Augello, Giuseppa; Emma, MARIA RITA; Azzolina, Antonina; Cervello, Melchiorre; Giannitrapani, Lydia
NUPR1 protects liver from lipotoxic injury by improving the endoplasmic reticulum stress response
2021 Teresa Borrello, M; Rita Emma, M; Listi, A; Rubis, M; Coslet, S; Augello, G; Cusimano, A; Cabibi, D; Porcasi, R; Giannitrapani, L; Soresi, M; Pantuso, G; Blyth, K; Montalto, G; Pin, C; Cervello, M; Iovanna, J
Potential uses of olive oil secoiridoids for the prevention and treatment of cancer: A narrative review of preclinical studies
2021 Emma, Mr; Augello, G; Di Stefano, V; Azzolina, A; Giannitrapani, L; Montalto, G; Cervello, M; Cusimano, A
Sensitivity of pancreatic cancer cells to chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals can be regulated by WT-TP53
2021 Abrams, Sl; Akula, Sm; Martelli, Am; Cocco, L; Ratti, S; Libra, M; Candido, S; Montalto, G; Cervello, M; Gizak, A; Rakus, D; Steelman, Ls; Mccubrey, Ja
Abilities of ?-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells
2020 Akula, Sm; Candido, S; Abrams, Sl; Steelman, Ls; Lertpiriyapong, K; Cocco, L; Ramazzotti, G; Ratti, S; Follo, My; Martelli, Am; Murata, Rm; Rosalen, Pl; Buenosilva, B; Matias de Alencar, S; Falasca, M; Montalto, G; Cervello, Melchiorre; Notarbartolo, M; Gizak, A; Rakus, D; Libra, M; Mccubrey, Ja
Cancer therapy and treatments during COVID-19 era
2020 Makula, Shaw; L Abrams, Stephen; Ssteelman, Linda; Saveriocandido, ; Massimolibra, ; Kvinlerpiriyapong, ; Luciococco, ; Giuliaramazzotti, ; Ratti, Stefano; Yfollo, Matilde; Mmartelli, Alberto; L Blalock, William; Piazzi, Manuela; Montalto, Giuseppe; Cervello, Melchiorre; Notarbartolo, Monica; Basecke, Jorg; A McCubrey, James
GSK-3 in liver diseases: Friend or foe?
2020 Emma MR; Augello G; Cusimano A; Azzolina A; Montalto G; McCubrey JA; Cervello M;
Hepatic and circulating levels of PCSK9 in morbidly obese patients: Relation with severity of liver steatosis
2020 R Emma, Maria; Giannitrapani, Lydia; Cabibi, Daniela; Porcasi, Rossana; Pantuso, Gianni; Augello, Giuseppa; V Giglio, Rosaria; Lo Re, Noemi; R Capitano, Adele; Montalto, Giuseppe; Soresi, Maurizio; Cervello, Melchiorre
Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell lines
2020 Chappell, Wh; Candido, S; Abrams, Sl; Akula, Sm; Steelman, Ls; Martelli, Am; Ratti, S; Cocco, L; Cervello, M; Montalto, G; Nicoletti, F; Libra, M; Mccubrey, Ja
New landscapes and horizons in hepatocellular carcinoma therapy.
2020 Cervello, M; Emma, Mr; Augello, G; Cusimano, A; Giannitrapani, L; Soresi, M; Akula, Sm; Abrams, Sl; Steelman, Ls; Gulino, A; Belmonte, B; Montalto, G; Mccubrey, Ja
Targeting GSK3 and Associated Signaling Pathways Involved in Cancer
2020 Duda, P; Akula, Sm; Abrams, Sl; Steelman, Ls; Martelli, Am; Cocco, L; Ratti, S; Candido, S; Libra, M; Montalto, G; Cervello, M; Gizak, A; Rakus, D; Mccubrey, Ja
Targeting NUPR1 with the small compound ZZW-115 is an efficient strategy to treat hepatocellular carcinoma
2020 Lan, W; Santofimiacastano, P; Xia, Y; Zhou, Z; Huang, C; Fraunhoffer, N; Barea, D; Cervello, M; Giannitrapani, L; Montalto, G; Peng, L; Iovanna, J
The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods
2020 Soresi M; Cabibi D; Giglio RV; Martorana S; Guercio G; Porcasi R; Terranova A; Lazzaro LA; Emma MR; Augello G; Cervello M; Pantuso G; Montalto G; Giannitrapani L;
The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment
2020 Augello G; Emma MR; Cusimano A; Azzolina A; Montalto G; McCubrey JA; Cervello M;
Therapeutic resistance in breast cancer cells can result from deregulated EGFR signaling
2020 S Steelman, Linda; H Chappell, William; M Akula, Shaw; L Abrams, Stephen; Cocco, Lucio; Manzoli, Lucia; Ratti, Stefano; M Martelli, Alberto; Montalto, Giuseppe; Cervello, Melchiorre; Libra, Massimo; Candido, Saverio; A McCubrey, James
Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells
2019 Abrams S.L.; Follo M.Y.; Steelman L.S.; Lertpiriyapong K.; Cocco L.; Ratti S.; Martelli A.M.; Candido S.; Libra M.; Murata R.M.; Rosalen P.L.; Montalto G.; Cervello M.; Gizak A.; Rakus D.; Mao W.; Lombardi P.; McCubrey J.A.
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells
2019 Akula, Sm; Candido, S; Libra, M; Abrams, Sl; Steelman, Ls; Lertpiriyapong, K; Ramazzotti, G; Ratti, S; Follo, My; Martelli, Am; Murata, Rm; Rosalen, Pl; Buenosilva, B; Matias de Alencar, S; Montalto, G; Cervello, M; Gizak, A; Rakus, D; Mao, W; Lin, Hl; Lombardi, P; Mccubrey, Ja
Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals
2019 Candido S; Abrams SL; Steelman LS; Lertpiriyapong K; Martelli AM; Cocco L; Ratti S; Follo MY; Murata RM; Rosalen PL; BuenoSilva B; de Alencar SM; Lombardi P; Mao W; Montalto G; Cervello M; Rakus D; Gizak A; Lin HL; Libra M; Akula SM; McCubrey JA;
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| The potential of the nutraceutical berberine in the treatment of hepatocellular carcinoma and other liver diseases such as NAFLD and NASH | 1-gen-2024 | Cervello, Melchiorre; Augello, Giuseppa; Cocco, Lucio; Ratti, Stefano; Follo, Matilde Y.; Martelli, Alberto M.; Cusimano, Antonella; Montalto, Giuseppe; Mccubrey, James A. | |
| GSK-3? Can Regulate the Sensitivity of MIA-PaCa-2 Pancreatic and MCF-7 Breast Cancer Cells to Chemotherapeutic Drugs, Targeted Therapeutics and Nutraceuticals | 1-gen-2021 | L Abrams, Stephen; M Akula, Shaw; K Meher, Akshaya; S Steelman, Linda; Gizak, Agnieszka; Duda, Przemysaw; Rakus, Dariusz; M Martelli, Alberto; Ratti, Stefano; Cocco, Lucio; Montalto, Giuseppe; Cervello, Melchiorre; Ruvolo, Peter; Libra, Massimo; Falzone, Luca; Candido, Saverio; A McCubrey, James | |
| Hepatocellular Carcinoma: A Difficult Cancer to Treat | 1-gen-2021 | Cusimano, Antonella; Soresi, Maurizio; Montalto, Giuseppe; Augello, Giuseppa; Emma, MARIA RITA; Azzolina, Antonina; Cervello, Melchiorre; Giannitrapani, Lydia | |
| NUPR1 protects liver from lipotoxic injury by improving the endoplasmic reticulum stress response | 1-gen-2021 | Teresa Borrello, M; Rita Emma, M; Listi, A; Rubis, M; Coslet, S; Augello, G; Cusimano, A; Cabibi, D; Porcasi, R; Giannitrapani, L; Soresi, M; Pantuso, G; Blyth, K; Montalto, G; Pin, C; Cervello, M; Iovanna, J | |
| Potential uses of olive oil secoiridoids for the prevention and treatment of cancer: A narrative review of preclinical studies | 1-gen-2021 | Emma, Mr; Augello, G; Di Stefano, V; Azzolina, A; Giannitrapani, L; Montalto, G; Cervello, M; Cusimano, A | |
| Sensitivity of pancreatic cancer cells to chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals can be regulated by WT-TP53 | 1-gen-2021 | Abrams, Sl; Akula, Sm; Martelli, Am; Cocco, L; Ratti, S; Libra, M; Candido, S; Montalto, G; Cervello, M; Gizak, A; Rakus, D; Steelman, Ls; Mccubrey, Ja | |
| Abilities of ?-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells | 1-gen-2020 | Akula, Sm; Candido, S; Abrams, Sl; Steelman, Ls; Lertpiriyapong, K; Cocco, L; Ramazzotti, G; Ratti, S; Follo, My; Martelli, Am; Murata, Rm; Rosalen, Pl; Buenosilva, B; Matias de Alencar, S; Falasca, M; Montalto, G; Cervello, Melchiorre; Notarbartolo, M; Gizak, A; Rakus, D; Libra, M; Mccubrey, Ja | |
| Cancer therapy and treatments during COVID-19 era | 1-gen-2020 | Makula, Shaw; L Abrams, Stephen; Ssteelman, Linda; Saveriocandido, ; Massimolibra, ; Kvinlerpiriyapong, ; Luciococco, ; Giuliaramazzotti, ; Ratti, Stefano; Yfollo, Matilde; Mmartelli, Alberto; L Blalock, William; Piazzi, Manuela; Montalto, Giuseppe; Cervello, Melchiorre; Notarbartolo, Monica; Basecke, Jorg; A McCubrey, James | |
| GSK-3 in liver diseases: Friend or foe? | 1-gen-2020 | Emma MR; Augello G; Cusimano A; Azzolina A; Montalto G; McCubrey JA; Cervello M; | |
| Hepatic and circulating levels of PCSK9 in morbidly obese patients: Relation with severity of liver steatosis | 1-gen-2020 | R Emma, Maria; Giannitrapani, Lydia; Cabibi, Daniela; Porcasi, Rossana; Pantuso, Gianni; Augello, Giuseppa; V Giglio, Rosaria; Lo Re, Noemi; R Capitano, Adele; Montalto, Giuseppe; Soresi, Maurizio; Cervello, Melchiorre | |
| Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell lines | 1-gen-2020 | Chappell, Wh; Candido, S; Abrams, Sl; Akula, Sm; Steelman, Ls; Martelli, Am; Ratti, S; Cocco, L; Cervello, M; Montalto, G; Nicoletti, F; Libra, M; Mccubrey, Ja | |
| New landscapes and horizons in hepatocellular carcinoma therapy. | 1-gen-2020 | Cervello, M; Emma, Mr; Augello, G; Cusimano, A; Giannitrapani, L; Soresi, M; Akula, Sm; Abrams, Sl; Steelman, Ls; Gulino, A; Belmonte, B; Montalto, G; Mccubrey, Ja | |
| Targeting GSK3 and Associated Signaling Pathways Involved in Cancer | 1-gen-2020 | Duda, P; Akula, Sm; Abrams, Sl; Steelman, Ls; Martelli, Am; Cocco, L; Ratti, S; Candido, S; Libra, M; Montalto, G; Cervello, M; Gizak, A; Rakus, D; Mccubrey, Ja | |
| Targeting NUPR1 with the small compound ZZW-115 is an efficient strategy to treat hepatocellular carcinoma | 1-gen-2020 | Lan, W; Santofimiacastano, P; Xia, Y; Zhou, Z; Huang, C; Fraunhoffer, N; Barea, D; Cervello, M; Giannitrapani, L; Montalto, G; Peng, L; Iovanna, J | |
| The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods | 1-gen-2020 | Soresi M; Cabibi D; Giglio RV; Martorana S; Guercio G; Porcasi R; Terranova A; Lazzaro LA; Emma MR; Augello G; Cervello M; Pantuso G; Montalto G; Giannitrapani L; | |
| The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment | 1-gen-2020 | Augello G; Emma MR; Cusimano A; Azzolina A; Montalto G; McCubrey JA; Cervello M; | |
| Therapeutic resistance in breast cancer cells can result from deregulated EGFR signaling | 1-gen-2020 | S Steelman, Linda; H Chappell, William; M Akula, Shaw; L Abrams, Stephen; Cocco, Lucio; Manzoli, Lucia; Ratti, Stefano; M Martelli, Alberto; Montalto, Giuseppe; Cervello, Melchiorre; Libra, Massimo; Candido, Saverio; A McCubrey, James | |
| Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells | 1-gen-2019 | Abrams S.L.; Follo M.Y.; Steelman L.S.; Lertpiriyapong K.; Cocco L.; Ratti S.; Martelli A.M.; Candido S.; Libra M.; Murata R.M.; Rosalen P.L.; Montalto G.; Cervello M.; Gizak A.; Rakus D.; Mao W.; Lombardi P.; McCubrey J.A. | |
| Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells | 1-gen-2019 | Akula, Sm; Candido, S; Libra, M; Abrams, Sl; Steelman, Ls; Lertpiriyapong, K; Ramazzotti, G; Ratti, S; Follo, My; Martelli, Am; Murata, Rm; Rosalen, Pl; Buenosilva, B; Matias de Alencar, S; Montalto, G; Cervello, M; Gizak, A; Rakus, D; Mao, W; Lin, Hl; Lombardi, P; Mccubrey, Ja | |
| Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals | 1-gen-2019 | Candido S; Abrams SL; Steelman LS; Lertpiriyapong K; Martelli AM; Cocco L; Ratti S; Follo MY; Murata RM; Rosalen PL; BuenoSilva B; de Alencar SM; Lombardi P; Mao W; Montalto G; Cervello M; Rakus D; Gizak A; Lin HL; Libra M; Akula SM; McCubrey JA; |